Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026, confirming the dematerialisation of securities and listing on stock exchanges.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has announced the voting results of its 45th Annual General Meeting (AGM), where all resolutions were passed with significant majority. The company has also declared a dividend for the financial year ended 31st March, 2026.

Gujarat Themis Biosyn Ltd

Themis Medicare Limited has announced the results of its 56th Annual General Meeting (AGM), where all resolutions were passed with requisite majority. The company also declared a dividend for the financial year ended 31st March, 2026.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has announced the results of its 45th Annual General Meeting (AGM), where all resolutions were passed with significant majority. The company also announced the appointment of a new director and declaration of dividend for the financial year ended 31st March, 2026.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has held its 45th Annual General Meeting (AGM) on September 30, 2026, where the company's financial statements for the year ended March 31, 2026, were adopted, and various resolutions were passed, including the appointment of a director, declaration of dividend, and approval to raise funds through a preferential issue.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has announced amendments to its Articles of Association, including the deletion of certain words and the insertion of new provisions related to the appointment of observers by financial institutions. The company has also approved a dividend of 67% and plans to raise funds through a preferential issue of equity shares.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has held its 45th Annual General Meeting (AGM) on September 30, 2026, where various resolutions were passed, including the appointment of a director, declaration of dividend, and approval of loan and guarantee from promoters.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has announced the closure of its trading window in accordance with SEBI regulations, effective from October 1, 2026, until the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has published a corrigendum to the notice of its 45th Annual General Meeting in newspapers as per SEBI listing regulations.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has issued a corrigendum to the notice of its 45th Annual General Meeting (AGM) to amend Resolution No. 8 and its explanatory statement to align with SEBI ICDR Regulations. The amendments relate to the issue of equity shares through a preferential issue and the utilization of funds.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has allotted Non-Convertible Debentures (NCDs) aggregating INR 585 Crores on private placement basis to finance its wholly subsidiary in Japan and general corporate purpose.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has issued an addendum to the notice of its 45th Annual General Meeting (AGM) to consider an amendment in its Articles of Association, specifically Article 119, to grant a right to a Financial Institution to appoint observers on the Board of Directors.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has submitted a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, stating that the promoters and promoter group have not acquired any shares or voting rights in the company, but have experienced a passive reduction in shareholding due to the allotment of 2,11,86,440 equity shares to non-promoters under a QIP issue.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has announced the outcome of its Board Meeting held on September 1, 2026, where it approved the issuance of up to 82,10,786 equity shares at an issue price of Rs. 408 per share, aggregating up to Rs. 335,00,00,688, to be issued on a private placement basis.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has announced the outcome of the Fund Raising Committee meeting held on August 28, 2026, for the allotment of equity shares through a Qualified Institutions Placement (QIP). The committee approved the issue and allotment of 2,11,86,440 equity shares at an issue price of Rs. 354 per equity share, aggregating to Rs. 749,99,99,760. The paid-up equity share capital of the company stands increased from Rs. 10,89,65,265 to Rs. 13,01,51,705.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has closed its Qualified Institutional Placement (QIP) issue period and allotted 2,11,86,440 equity shares to eligible QIBs at Rs. 354 per share, including a premium of Rs. 353 per share.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026, inter alia, to consider and approve raising funds through issue of equity shares and/or convertible warrants through preferential issue on a private placement basis.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has approved a qualified institutions placement (QIP) of equity shares to raise funds, with a floor price of ₹ 372.57 per share and an option to offer a discount of up to 5%.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has announced the audited financial statements for the year ended March 31, 2026, along with the audit reports issued by the Statutory Auditor. The financial statements are available on the company's website.

Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd has amended its Articles of Association, specifically deleting a clause related to share valuation by a registered valuer or approved valuer.